Indian scientists develop new drug for blood cancer

By Bhavya Khullar

Published on June 9, 2017

A group of Indian scientists have found a new compound that effectively kills leukemic cancer cells.

Codenamed5g, the new drug can killover 70 pe rcent blood cancer cells in petri dish in 48 hours at an extremely low concentration. It did not affect healthy blood cells, which signifies that is toxic to cancer cells. “After treating with 5g cancer cells either entered cell death or revertedback to normal cell cycle”, say scientists who have tested this new compound.

The new compound has been found to be most effective in leukemic cells, while other cancer cell lines like colorectal and cervical showed less effect. It accumulates death-inducing reactive oxygen species in cancer cells leading to breaks in DNA, which ultimately causes cell death.

“We are working with Mysuru University to improve its efficacy. We believe that it has the potential to be developed as an anti-leukemic agent”, says Professor SatheesRaghavan, a member of the research team at Indian Institute of Science, Bangalore. The research findings have been published in journal Scientific Reports.

The drug has been tested in laboratory animals. Daily doses of 5g for two weeks reduced the size of tumor in mice. It was non-toxic and moderately increased the life span of diseased mice. The tumor regression was incomplete, because of which,the scientists suggest that 5g needs combinational compounds to increase its efficiency. “We have identified a novel inhibitor of cell cycle and provide evidence at proof of principle level that 5g can be developed as a potent anticancer molecule for chemotherapy”, they say.

This study was done at the Indian Institute of Science in Bangalore, University of Mysore in Mysuru, and Institute of Bioinformatics and Applied Biotechnology in Bangalore. It was supported by IISc-Department of Biotechnology partnership. The research team included Mahesh Hegde, Supriya VVartak, Chandagirikoppal VKavitha, HanumappaAnanda, Doddakunche SPrasanna, VidyaGopalakrishnan, BibhaChoudhary, Kanchugarakoppal, S Rangappa, and Sathees C Raghavan.

This is from a Syndicated feed from India Science Wire.

Adulteration Aged care AIDS ambulances and emergency care birth deliveries blood banks Budget Cancer Cancer cases in India Cancer in South Korea cataract cervical cancer China Cholera disease in India Communicable diseases Comparison of India in Government Health Expenditure Dental Colleges in India Dentist Diabetes Diabetes in Asia Diabetes in India Disease in eastern states of India Diseases Doctors Domestic General Government Health Expenditure Drinking water Expenditure Fertility rate Food adulteration Food testing labs Funds GGHE-D per Capita in India Global Data Government Medical Colleges H1N1 Health Expense Report Health Infrastructure Health Survey Healthcare Education Hepatitis HIV HIV in India Hospitals Immunisation Immunization coverage Infrastructure Inoculation Insurance Kala Azar disease Life expectancy Maternal health maternal mortality Medical education Medical Research Mental Health Data Milk Adulteration National Organ and Tissue Transplant Organization National Organ Transplant Programme non-communicable diseases NOTTO Organ Donation Organ Transplant Palliative care Pharma PMSSY Medical Colleges Polio Pradhan Mantri Swasthya Suraksha Yojana Public Health Rabies Rabies deaths Registered Dental doctors Registered Doctors with State Dental Council Road Accidents RTI Data Sanitation Sex Ratio Smart Cities Snake bite State Health Expenditure Report in India Suicide rate in Asia Suicide rate in India Technology Tuberculosis Tuberculosis disease in asia Tuberculosis in India Typhoid Vaccination Vector-borne Diseases water borne diseases